Artículos por temáticas

Prenatal risk factors for Tourette Syndrome: a systematic review.

Chao TK, Hu J, Pringsheim T.

BMC Pregnancy Childbirth. 2014 Jan 30;14:53. doi: 10.1186/1471-2393-14-53. Review.

Individualized assessments in treatment research: an examination of parent-nominated target problems in the treatment of disruptive behaviors in youth with Tourette syndrome.

McGuire JF, Sukhodolsky DG, Bearss K, Grantz H, Pachler M, Lombroso PJ, Scahill L.

Child Psychiatry Hum Dev. 2014 Dec;45(6):686-94. doi: 10.1007/s10578-014-0437-7.

A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome.

Gilbert DL, Budman CL, Singer HS, Kurlan R, Chipkin RE.

Clin Neuropharmacol. 2014 Jan-Feb;37(1):26-30. doi: 10.1097/WNF.0000000000000017.

Abnormal baseline brain activity in drug-naïve patients with Tourette syndrome: a resting-state fMRI study.

Cui Y, Jin Z, Chen X, He Y, Liang X, Zheng Y.

Front Hum Neurosci. 2014 Jan 2;7:913. doi: 10.3389/fnhum.2013.00913.

Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.

Castellan Baldan L, Williams KA, Gallezot JD, Pogorelov V, Rapanelli M, Crowley M, Anderson GM, Loring E, Gorczyca R, Billingslea E, Wasylink S, Panza KE, Ercan-Sencicek AG, Krusong K, Leventhal BL, O

Neuron. 2014 Jan 8;81(1):77-90. doi: 10.1016/j.neuron.2013.10.052. Erratum in: Neuron. 2014 Jun 4;82(5):1186-7.

A patient-led educational program on Tourette Syndrome: impact and implications for patient-centered medical education.

Graham KL, Green S, Kurlan R, Pelosi JS.

Teach Learn Med. 2014;26(1):34-9. doi: 10.1080/10401334.2013.857339.

Tics are caused by alterations in prefrontal areas, thalamus and putamen, while changes in the cingulate gyrus reflect secondary compensatory mechanisms.

Müller-Vahl KR, Grosskreutz J, Prell T, Kaufmann J, Bodammer N, Peschel T.

BMC Neurosci. 2014 Jan 7;15:6. doi: 10.1186/1471-2202-15-6.

Uncovering the complexity of Tourette syndrome, little by little.

Gorman DA, Abi-Jaoude E.

Br J Psychiatry. 2014 Jan;204(1):6-8. doi: 10.1192/bjp.bp.113.135996.

Treatment of Tourette syndrome.

Kurlan RM.

Neurotherapeutics. 2014 Jan;11(1):161-5. doi: 10.1007/s13311-013-0215-4.

Structural Connectivity in Gilles de la Tourette Syndrome.

Chelse AB, Blackburn JS.

Pediatr Neurol Briefs. 2015 Apr;29(4):26. doi: 10.15844/pedneurbriefs-29-4-1.

Risk of Tics with Psychostimulants for ADHD.

Millichap JG.

Pediatr Neurol Briefs. 2015 Dec;29(12):95. doi: 10.15844/pedneurbriefs-29-12-6.

Deep Brain Stimulation for Tourette-Syndrome: A Systematic Review and Meta-Analysis.

Baldermann JC, Schüller T, Huys D, Becker I, Timmermann L, Jessen F, Visser-Vandewalle V, Kuhn J.

Brain Stimul. 2016 Mar-Apr;9(2):296-304. doi: 10.1016/j.brs.2015.11.005.

Sources of Disability in Tourette Syndrome: Children vs. Adults.

Kompoliti K.

Tremor Other Hyperkinet Mov (N Y). 2016 Jan 11;5:318. doi: 10.7916/D8Z60NQ2. Review.

Impact of Perceived Stress, Anxiety-Depression and Social Support on Coping Strategies of Parents Having A Child With Gilles de la Tourette Syndrome.

Goussé V, Czernecki V, Denis P, Stilgenbauer JL, Deniau E, Hartmann A.

Arch Psychiatr Nurs. 2016 Feb;30(1):109-13. doi: 10.1016/j.apnu.2015.08.017.

A DTI study on the corpus callosum of treatment-naïve boys with 'pure' Tourette syndrome.

Wolff N, Luehr I, Sender J, Ehrlich S, Schmidt-Samoa C, Dechent P, Roessner V.

Psychiatry Res. 2016 Jan 30;247:1-8. doi: 10.1016/j.pscychresns.2015.12.003.